Ferrucci et al., 2020. Prune-1 drives polarization of tumor-associated macrophages (TAMs) within the lung metastatic niche in triple negative breast cancer. iSCIENCE-D-20-01279. FiguresHigherResolution

Published: 11 December 2020| Version 1 | DOI: 10.17632/zdmthbkcgj.1
Contributor:
Massimo Zollo

Description

Prune-1 drives polarization of tumor-associated macrophages (TAMs) within the lung metastatic niche in triple-negative breast cancer Veronica Ferrucci et al., iSCIENCE-D-20-01279. Abstract: M2 tumor-associated macrophages (M2-TAMs) in the tumor microenvironment represent a prognostic indicator for poor outcome in triple-negative breast cancer (TNBC). Here we show that Prune-1 overexpression in human TNBC patients has positive correlation to lung metastasis and infiltrating M2-TAMs. Thus, we demonstrate that Prune-1 promotes lung metastasis in a genetically engineered mouse model of metastatic TNBC augmenting M2-polarization of TAMs within the tumor microenvironment. Thus, this occurs through TGF-β enhancement, IL-17F secretion and extracellular vesicle protein content modulation. We also find murine inactivating gene variants in human TNBC patient cohorts that are involved in activation of the innate immune response, cell adhesion, apoptotic pathways, and DNA repair. Altogether we indicate that the overexpression of Prune-1, IL-10, COL4A1, ILR1, and PDGFB, together with inactivating mutations of PDE9A, CD244, Sirpb1b, SV140, Iqca1, and PIP5K1B genes, might represent a route of metastatic lung dissemination which need future prognostic validations. Below are Figures of the manuscript in Higher Resoltion

Files

Steps to reproduce

The Methodology is represented in “Ferrucci et al., 2020. Prune-1 drives polarization of tumor-associated macrophages (TAMs) within the lung metastatic niche in triple negative breast cancer. iSCIENCE-D-20-01279

Institutions

Azienda Ospedaliera Universitaria Federico II, CEINGE Biotecnologie Avanzate sc a rl, Universita degli Studi di Napoli Federico II

Categories

Genetics, Breast Cancer, Animal Biomedical Model

License